Publication Name	World Journal of Virology
Manuscript ID	22968
Country	Switzerland

Received	2015-10-08 14:11
Peer-Review Started	2015-10-08 15:14
To Make the First Decision	2015-12-04 11:12
Return for Revision	2015-12-07 11:43
Revised	2016-01-09 21:15
Second Decision	2016-01-22 15:10
Accepted by Journal Editor-in-Chief	2016-01-23 11:38
Accepted by Executive Editor-in-Chief	2016-01-31 14:23
Articles in Press	2016-01-31 14:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-04-13 11:30
Publish the Manuscript Online	2016-05-06 13:48

ISSN	2220-3249 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Virology
Manuscript Type	Minireviews
Article Title	Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs
Manuscript Source	Invited Manuscript
All Author List	Erika Castro and Elena Roger
Funding Agency and Grant Number
Corresponding Author	Erika Castro, MD, PhD, Addiction Medicine Centre, Service of Community Psychiatry, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, Rue St-Martin 7, CH-1003 Lausanne, Switzerland. erika.castro-bataenjer@chuv.ch
Key Words	Co-infection treatment; Human T lymphotropic virus-1/2 screening among people who inject drugs; People who inject drugs; Hepatitis C virus/human T lymphotropic virus-1/2 co-infection; Human T lymphotropic virus; Hepatitis C virus
Core Tip	People who inject drugs (PWID) are at higher risk of infection with blood-borne viruses and even co-infections. Co-infections with human immunodeficiency virus and human T lymphotropic virus (HTLV)-1/2 are common, and well-studied, among PWID; however, the rise of HTLV-1/2 co-infections with hepatitis C virus (HCV) has gained much research attention and studies have shown that the former influences the chronic disease course of the latter. This review summarizes the data from 34 articles on HCV/HTLV-1/2 co-infection in the PWID patient population, including current treatment options and impact on virological outcome.
Publish Date	2016-05-06 13:48
Citation	Castro E, Roger E. Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs. World J Virol 2016; 5(2): 68-72
URL	http://www.wjgnet.com/2220-3249/full/v5/i2/68.htm
DOI	http://dx.doi.org/10.5501/wjv.v5.i2.68

Full Article (PDF)	WJV-5-68.pdf
Full Article (Word)	WJV-5-68.doc
Manuscript File	22968-Review.docx
Answering Reviewers	22968-Answering reviewers.pdf
Audio Core Tip	22968-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22968-Conflict-of-interest statement.pdf
Copyright License Agreement	22968-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	22968-Language certificate.pdf
Supplementary Material	Supplementary_Material_20151008141002.pdf
Peer-review Report	22968-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	22968-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	22968-Scientific misconduct check.pdf
Scientific Editor Work List	22968-Scientific editor work list.pdf